-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Abvc Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q1 2025.
- Abvc Biopharma, Inc. Operating Income (Loss) for the quarter ending March 31, 2025 was -$693K, a 75.6% increase year-over-year.
- Abvc Biopharma, Inc. Operating Income (Loss) for the twelve months ending March 31, 2025 was -$2.56M, a 66.7% increase year-over-year.
- Abvc Biopharma, Inc. annual Operating Income (Loss) for 2024 was -$4.71M, a 30.5% increase from 2023.
- Abvc Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$6.77M, a 55.2% increase from 2022.
- Abvc Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$15.1M, a 29.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)